Provista is Bioscience Company of the Year
About Breast Cancer: Facts and
Diagnostic Methods
What are the facts about breast cancer?
Breast cancer is the most common form of cancer in women. One in eight women in the U.S. will develop breast cancer in her lifetime. In 2006, the American Cancer Society estimated that more than 200,000 new cases of breast cancer were diagnosed and 40,000 women died of the disease in the U.S. alone, making it the largest cause of cancer-related death for women.
However, the five-year survival rate for breast cancer is now about 96 percent if the cancer has not spread at the time of diagnosis. Therefore, early detection is crucial to a woman’s ability to survive this potentially deadly disease.
The
BT Test provides an entirely new capability in overcoming this critical life-and-death challenge by detecting breast cancer at the molecular level and enabling physicians to better diagnose breast cancer in its early stages – and begin treatment before it’s too late.
Clinical Research and Medical
Information on the BT Test
What is the BT Test?
The Biomarker Translation Test, or the BT Test, is a blood test that detects and measures the levels of key biomarkers that are associated with breast cancer. A biomarker is a protein found in the blood whose presence can indicate the existence of disease.
The BT Test has successfully demonstrated an accuracy of greater than 80 percent in studies involving breast cancer-positive and non-breast cancer subjects, the latter group being comprised of healthy women, as well as women with benign breast conditions.
What clinical studies have been completed on the BT Test?
In clinical study
Provista Diagnostics , the clinical services subsidiary of Provista Life Sciences, enrolled a total of 467 women subjects: 304 from biopsy patients and 163 age-matched, statistically equivalent patients without cancer. With this clinical study Provista was able to an accuracy of detecting breast cancer of greater than 80 percent.
For more information on our study of the BT Test for breast cancer please download our
clinical study summary here.